Evaluation of the effectiveness of gabapentin in the control of renal colic pai

Phase 3

Recruiting

Conditions: Acute renal colic pain.
Unspecified renal colic

Registration Number: IRCT20200322046833N2

Lead Sponsor: Tehran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

Patients aged 18-85 years with moderate to severe acute renal colic pain
Obtaining informed written consent from the patient

Exclusion Criteria

History of severe kidney failure
History of moderate to severe liver failure
History of allergic reactions to gabapentin or its formulation components
Consumption of pregabalin and gabapentin during the last week
Intolerance to food
Dissatisfaction with entering the study
History of unknown lung disease or history of pulmonary insufficiency in COPD or fibrosis of the lung

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The average pain intensity at 4 o'clock. Timepoint: Measurement of pain intensity at the time of patient admission and then every 5 minutes after drug administration and finally 4 and 8 hours after drug administration. Method of measurement: Ask the patient how much pain using the Visual Analogue Scale method.

Secondary Outcome Measures

Name	Time	Method
The average amount of morphine consumed in each group. Timepoint: At the time of the patient's arrival and every 5 minutes after the drug is administered, morphine is added to the treatment as rescue if the pain is severe (pain above 7 out of 10). Method of measurement: Sum of the amount of morphine consumed from the moment of arrival until the patient is discharged.;Mean pain control time. Timepoint: From the moment the patient arrives until discharge. Method of measurement: From ketorolac injection to pain control below 5, no narcotics (at least 3 hours after the last narcotics) or discharge.